The 2 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +382.46% increase from the last price of 1.14.
The current consensus among 2 polled investment analysts is to Buy stock in Citius Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.11
Reporting Date Sep 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.